Sr. No. |
Age (Yrs) |
Females |
Males |
Total no of cases (%) |
1 |
0 -10 |
3 |
1 |
4(3) |
2 |
11-20 |
12 |
19 |
31(23.4) |
3 |
21-30 |
6 |
19 |
25(18.9) |
4 |
31-40 |
10 |
5 |
15(11.3) |
5 |
41-50 |
4 |
15 |
19(14.3) |
6 |
51-60 |
9 |
10 |
19(14.3) |
7 |
61-70 |
5 |
4 |
9(6.8) |
8 |
71-80 |
3 |
7 |
10(7.5) |
|
Total |
52 |
80 |
132 |
S. |
Cause |
Males |
Females |
Total No.
of |
1. |
Megaloblastic
anemia |
43 |
24 |
67 (50.7%) |
2. |
Hypersplenism |
7 |
7 |
14
(10.6%) |
3. |
Malaria |
9 |
4 |
13 (9.8%) |
4. |
Aplastic anemia
|
5 |
5 |
10(7.5%) |
5. |
Subleukaemic phase of acute leukemia(AL) |
6 |
6 |
12 (9.0%) |
6. |
Kala
–azar(KA) |
1 |
0 |
1 (0.75%) |
7. |
Infection
and sepsis(INF) |
1 |
1 |
2(1.5%) |
8. |
Drug
induced |
0 |
1 |
1 (0.75%) |
9. |
Hepatitis(HBsag) |
0 |
1 |
1 (.75%) |
10. |
HIV
infection |
1 |
- |
1 (.75%) |
11. |
Alcoholism |
1 |
- |
1 (.75%) |
12. |
Chronic
renal failure(CRF) |
1 |
1 |
2 (1.5%) |
13. |
Myelodysplastic
syndrome |
2 |
1 |
3 (2.2%) |
14 |
SLE |
0 |
1 |
1(0.75%) |
15 |
Trauma |
2 |
0 |
2(0.75%) |
16 |
Wilson
Disease |
1 |
0 |
1(0.75%) |
|
Total |
80 |
52 |
132 |
CAUSE | Anisopoikio-Cytosis | Circulating Erythroblast | Hypersegmented Neutrophil | |
Megaloblastic Anemia | 67 | 67(100) | 5(7.4) | 55(82) |
Malaria | 13 | 3(23.0) | 1(7.6) | |
Hyperspleenism | 14 | 7(50) | 1(7.1) | |
Aplastic Anemia | 10 | 2(20) | ||
Acute leukemia | 12 | 2(16.3) | ||
Myelodyaplastic syndrome | 3 | 2(66.6) | ||
Infection | 2 | - | 1(50) |
Sr.No. |
Parameter |
Range |
Mean (±SD) |
1 |
TLC
(x 103/µL) |
1.8-3.8 |
2.7(.92) |
3 |
Haemoglobin
(gm/dl) |
3.8-10.0 |
6.5(1.6) |
4 |
Haematocrit
(%) |
11.8-30.0 |
21.1(5.7) |
5 |
MCV
(fl) |
79.8-96.5 |
93(3.2) |
6 |
MCH
(pg) |
21.3-31.2 |
30(.9) |
7 |
MCHC
(gm/dl) |
26.7-34.1 |
33(1.6) |
8 |
Platelet
count (x 103/µL) |
3-100 |
35.0(25.9) |
9 |
Reticulocyte
count (%) |
0.4-1 |
0.7(.3) |
Cause |
Clinical Presentation |
||||||
|
Total
Cases |
Fever % |
Pallor % |
Bleeding
% |
Icterus
% |
Spleen % |
Liver % |
Megaloblastic
Anemia |
67 |
39(58.2) |
67(100) |
4(5.9) |
15(22.3) |
17(25.3) |
17(25.3) |
Malaria |
13 |
13(100) |
10(76.9) |
1(7.6) |
5(38) |
3(23) |
5(38) |
Hyperspleenism |
14 |
4(28.5) |
13(92) |
2(14) |
4(28) |
14(100) |
4(28) |
Aplastic
anemia |
10 |
6(60) |
10(100) |
4(40) |
0 |
0 |
0 |
Acute leukemia |
12 |
7(58.3) |
12(100) |
3(25) |
1 |
2(16.6) |
1(8.3) |
Myelodyspalstic
syndrome |
3 |
2(66.6) |
3(100) |
0 |
0 |
0 |
0 |
Infection |
2 |
1(50) |
2(100) |
0 |
0 |
2(100) |
2(100) |
Cause |
TLC(X103/µl) |
HB(gm/dl) |
HCT(%) |
MCV(fl) |
MCH(pg) |
MCHC |
PLTx103/µl) |
Megaloblstic Anemia |
3.2(.75) |
5.0(1.8) |
17.8(5.18) |
102.3(10.1) |
32.5(5.3) |
34(2.8) |
69.5(36.0) |
Malaria |
3.6(.50) |
8(2) |
24.1(5.6) |
79.1(3.5) |
27(3.1) |
29(.5) |
56.0(22.8) |
Hyperspleenism |
3.4(.95) |
7.0(2.4) |
23(6.9) |
75.3(15.4) |
24(8.3) |
32(2.5) |
64.3(37.7) |
Aplastic Anemia |
2.7(.92) |
6.5(1.6) |
21.1(5.7) |
93(3.2) |
30(.9) |
33(1.6) |
35.0(25.9) |
Acute Leukemia |
2.7(.96) |
6.6(1.5) |
20(4.9) |
90(4.0) |
30(2) |
32(.9) |
52.3(22.5) |
|
Maturation |
No. of cases (%) |
1 |
Normoblastic |
32 (31.6) |
2 |
Megaloblastic |
57 (56.4) |
3 |
Predominantly
megaloblastic with micronormoblastic |
12 (11.8) |
|
Total no.
of cases |
101 (100) |